Osteoblast differentiation is functionally associated with decreased AMP kinase activity

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 740-749

  Kasai, Takayuki ^a   Bandow, Kenjiro ^a   Suzuki, Hiraku ^a   Chiba, Norika ^a   Kakimoto, Kyoko ^a   Ohnishi, Tomokazu ^a   Kawamoto, Shin Ichiro ^a   Nagaoka, Eiichi ^a   Matsuguchi, Tetsuya ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADENYLATE KINASE ALPHA; BONE SIALOPROTEIN; CELL MARKER; GLUCOSE; METFORMIN; OSTEOCALCIN; OSTEOPONTIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; RIBONUCLEOTIDE; RUNX2 PROTEIN, MOUSE; SIALOGLYCOPROTEIN; SPP1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ADIPOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CELL STRAIN 3T3; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ALKALINE PHOSPHATASE; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; GLUCOSE; HYPOGLYCEMIC AGENTS; METFORMIN; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; PHOSPHORYLATION; RIBONUCLEOTIDES; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 70449699786     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21917     Document Type: Article

References (40)

1. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. 1990. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:213-221. (Pubitemid 20143310)
2. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. 2000. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346:659-669. (Pubitemid 30171026)
3. Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L. 2006. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 536:38-46.
4. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 1995. 5-aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565.
5. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. 1998. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 273:35347-35354. (Pubitemid 29028244)
6. Dagon Y, Avraham Y, Berry EM. 2006. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 340:43-47. (Pubitemid 41827645)
7. Davies SP, Helps NR, Cohen PT, Hardie DG. 1995. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett 377:421-425.
8. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, Xue A, Montag AG, Luu HH, Haydon RC, He TC. 2008. Regulation of osteogenic differentiation during skeletal development. Front Biosci 13:2001-2021. (Pubitemid 351589231)
9. Dyck JR, Gao G, Widmer J, Stapleton D, Fernandez CS, Kemp BE, Witters LA. 1996. Regulation of 50-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem 271:17798-17803. (Pubitemid 26250755)
10. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14:661-673. (Pubitemid 351622608)
11. Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, Key L, Singh AK, Singh I. 2006. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 3:31. (Pubitemid 44378734)
12. Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, Blanchard D, Gygi SP, Brunet A. 2007. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17:1646-1656. (Pubitemid 47503807)
13. Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, Viollet B, Hue L. 2007. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J 404:499-507. (Pubitemid 46953924)
14. Habinowski SA, Witters LA. 2001. The effects of AICAR on adipocyte differentiation of 3T3- L1 cells. Biochem Biophys Res Commun 286:852-856. (Pubitemid 32924850)
15. Hardie DG. 2007. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785.
16. Hauschka PV, Lian JB, Cole DE, Gundberg CM. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047. (Pubitemid 19184853)
17. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879-27887. (Pubitemid 26367365)
18. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. 1998. Aserine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184-187.
19. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ. 2005. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694-699. (Pubitemid 41597699)
20. Jacobs RL, Lingrell S, Dyck JR, Vance DE. 2007. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4- ribofuranoside is independent of AMP-activated protein kinase activation. J Biol Chem 282:4516-4523. (Pubitemid 47100967)
21. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38-43. (Pubitemid 28027876)
22. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T. 2007. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8:51. (Pubitemid 351772684)
23. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T. 2008. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun 375:414-419.
24. Komori T. 2008. Regulation of bone development and maintenance by Runx2. Front Biosci 13:898-903. (Pubitemid 351594735)
25. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
26. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee SH, Shong M, Kim JM, Kim J, Chung J. 2007. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447:1017-1020. (Pubitemid 46975745)
27. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, Zhu Y. 2008. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1789-1795.
28. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
29. Matsuguchi T, Kraft AS. 1998. Regulation of myeloid cell growth by distinct effectors of Ras. Oncogene 17:2701-2709. (Pubitemid 28554229)
30. Matsuguchi T, Musikacharoen T, Johnson TR, Kraft AS, Yoshikai Y. 2001. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol Cell Biol 21:6999-7009.
31. McCarty MF. 2004. Chronic activation of AMP-activated kinase as a strategy for slowing aging. Med Hypotheses 63:334-339.
32. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771. (Pubitemid 27516179)
33. Raisz LG, Kream BE. 1983. Regulation of bone formation. N Engl J Med 309:29-35.
34. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646. (Pubitemid 41780780)
35. Stein SC, Woods A, Jones NA, Davison MD, Carling D. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345:437-443. (Pubitemid 30099070)
36. Tong J, Zhu MJ, Underwood KR, Hess BW, Ford SP, Du M. 2008. AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells. J Anim Sci 86:1296-1305. (Pubitemid 351860778)
37. Witters LA. 2001. The blooming of the French lilac. J Clin Invest 108:1105-1107.
38. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. 2003. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18:705-715.
39. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ. 1998. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392:622-626. (Pubitemid 28207722)
40. Zang Y, Yu LF, Pang T, Fang LP, Feng X, Wen TQ, Nan FJ, Feng LY, Li J. 2008. AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase. J Biol Chem 283:6201-6208.